Wiedermann G - Search Results

1

Inactivated hepatitis A vaccine: long-term antibody persistence.

Wiedermann G, Kundi M, Ambrosch F, Safary A, D'Hondt E, Delem A. Wiedermann G, et al. Vaccine. 1997 Apr-May;15(6-7):612-5. doi: 10.1016/s0264-410x(96)00242-3. Vaccine. 1997. PMID: 9178459 Clinical Trial.

2

Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees.

Garner-Spitzer E, Kundi M, Rendi-Wagner P, Winkler B, Wiedermann G, Holzmann H, Herzog C, Kollaritsch H, Wiedermann U. Garner-Spitzer E, et al. Among authors: wiedermann g. Vaccine. 2009 Jan 7;27(2):197-204. doi: 10.1016/j.vaccine.2008.10.045. Epub 2008 Nov 7. Vaccine. 2009. PMID: 18996424 Clinical Trial.

3

Persistence of vaccine-induced antibody to hepatitis A virus.

Wiedermann G, Ambrosch F, André FE, D'Hondt E, Delem A, Safary A. Wiedermann G, et al. Vaccine. 1992;10 Suppl 1:S129-31. doi: 10.1016/0264-410x(92)90566-3. Vaccine. 1992. PMID: 1335643 Clinical Trial.

4

Simultaneous vaccination against hepatitis A and B: results of a controlled study.

Ambrosch F, André FE, Delem A, D'Hondt E, Jonas S, Kunz C, Safary A, Wiedermann G. Ambrosch F, et al. Among authors: wiedermann g. Vaccine. 1992;10 Suppl 1:S142-5. doi: 10.1016/0264-410x(92)90570-a. Vaccine. 1992. PMID: 1335647 Clinical Trial.

5

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.

Wiedermann G, Ambrosch F, Kollaritsch H, Hofmann H, Kunz C, D'Hondt E, Delem A, André FE, Safary A, Stéphenne J. Wiedermann G, et al. Vaccine. 1990 Dec;8(6):581-4. doi: 10.1016/0264-410x(90)90013-c. Vaccine. 1990. PMID: 1965077 Clinical Trial.

6

Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine.

Wiedermann G, Ambrosch F, Kremsner P, Kunz C, Hauser P, Simoen E, André F, Safary A. Wiedermann G, et al. Postgrad Med J. 1987;63 Suppl 2:109-13. Postgrad Med J. 1987. PMID: 3317344 Clinical Trial.

7

Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.

Ambrosch F, Frisch-Niggemeyer W, Kremsner P, Kunz C, André F, Safary A, Wiedermann G. Ambrosch F, et al. Among authors: wiedermann g. Postgrad Med J. 1987;63 Suppl 2:129-35. Postgrad Med J. 1987. PMID: 3317348

8

Multicentre dose range study of a yeast-derived hepatitis B vaccine.

Wiedermann G, Scheiermann N, Goubau P, Ambrosch F, Gesemann M, De Bel C, Kremsner P, Paar D, Kunz C, Hauser P, et al. Wiedermann G, et al. Vaccine. 1987 Sep;5(3):179-83. doi: 10.1016/0264-410x(87)90096-x. Vaccine. 1987. PMID: 3673204 Clinical Trial.

9

Thermostability of an inactivated hepatitis A vaccine stored at 37 degrees C for one week.

Wiedermann G, Ambrosch F, André FE, Delem A, D'Hondt E, Safary A. Wiedermann G, et al. J Med Virol. 1994 Dec;44(4):442. doi: 10.1002/jmv.1890440423. J Med Virol. 1994. PMID: 7897377 No abstract available.

10

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.

Ambrosch F, Wiedermann G, André FE, Delem A, Gregor H, Hofmann H, D'Hondt E, Kundi M, Wynen J, Kunz C. Ambrosch F, et al. Among authors: wiedermann g. J Med Virol. 1994 Dec;44(4):452-6. doi: 10.1002/jmv.1890440426. J Med Virol. 1994. PMID: 7897380 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters